You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
Bioprocessing of Plasma Therapeutic Proteins using Sequential Affinity Monolithic
SBC: PROTHERA BIOLOGICS, INC. Topic: N/ADESCRIPTION (provided by applicant): Plasma fractionation is one of the largest industry segments in global therapeutic protein manufacture. The United States plays an important role in this industry since it represents the largest plasma collection and manufacturing base that accounts for more than 50% of the world supply of plasma. Even though more than 22 million liters of plasma are collected ...
SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health -
Role of Inter-alpha Inhibitors in Anthrax Intoxication
SBC: PROTHERA BIOLOGICS, INC. Topic: NIAIDDESCRIPTION (provided by applicant): Anthrax is recognized as a class A bio-threat microbial pathogen that is readily weaponized and exceedingly difficult to treat. This bacterium is highly virulent inducing lethal infection in immunologically normal hosts by its intrinsic capacity to disseminate rapidly and induce sepsis, along with its ability to generate two highly potent exotoxins, lethal toxi ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Rapid detection of neonatal sepsis
SBC: PROTHERA BIOLOGICS, INC. Topic: NICHDDESCRIPTION (provided by applicant): The primary goal of this proposed research is to develop a rapid point-of-care (POC) test that can be used to identify neonatal sepsis in high-risk infants in a simple, user-friendly and portable device suitable for usein the NICU setting. Since sepsis presents a very serious threat to neonates, there is an urgent need to obtain confirmation as soon as possible ...
SBIR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
Inter-alpha-inhibitors in Hypoxic-Ischemic Brain Injury
SBC: PROTHERA BIOLOGICS, INC. Topic: NINDSDESCRIPTION (provided by applicant): Neonatal hypoxia-ischemia (HI) remains a major cause of acute perinatal brain injury, leading ultimately to neurologic dysfunction manifesting as cerebral palsy, mental retardation, and epilepsy. Cerebral oxygen deprivation and/or reduced blood flow due to umbilical cord occlusion, prolonged labor, and/or intracranial hemorrhage produce an inflammatory respons ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Role of Inter-alpha Inhibitors in Anthrax Intoxication
SBC: PROTHERA BIOLOGICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The primary goal of this proposal is to demonstrate the feasibility of utilizing Inter-alpha Inhibitor proteins (lalp) as an effective protective agent against exposure to anthrax, a lethal biological warfare agent. Inter-alpha inhibitor proteins are natural serine protease inhibitors found in relatively high concentration in human plasma. The protein complex h ...
SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health -
Characterization of Consolidation of Non-Spherical Powders
SBC: MATSYS INC Topic: N/AWe propose to characterize the early stage of consolidation of non-spherical powders to further the development of process models to enable simulation of powder metallurgy manufacturing for the consumer market, especially the automotive industry. Typically, spherical powders with a narrow size distribution are used for aerospace applications, while low-cost powders with irregular shapes and a wide ...
SBIR Phase I 1997 Department of Commerce -
Characterization of Consolidation of Non-Spherical Powders
SBC: MATSYS INC Topic: N/AWe propose to characterize the early stage of consolidation of non-spherical powders to further the development of process models to enable simulation of powder metallurgy manufacturing for the consumer market, especially the automotive industry. Typically, spherical powders with a narrow size distribution are used for aerospace applications, while low-cost powders with irregular shapes and a wide ...
SBIR Phase II 1998 Department of Commerce -
SBIR Phase I: In-Processing Femtosecond Energy Diffusion Sensing of Microscale Thermal Transfer in
SBC: MATSYS INC Topic: N/AN/A
SBIR Phase I 1998 National Science Foundation -
Development of a novel human rhinovirus vaccine
SBC: BIOLOGICAL MIMETICS INC Topic: NIAIDDESCRIPTION (provided by applicant): Human Rhinoviruses (HRV) cause approximately one third of the 60 million cases of common cold each year in the US and therefore are one of the most economically important human diseases of developed countries. Although rhinoviruses are not generally considered killer viruses, more recent studies have shown that rhinoviruses are a significant source of hosp ...
SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health -
Masking the GH-loop: model for human Rhinovirus vaccine
SBC: BIOLOGICAL MIMETICS INC Topic: N/AOne of the most challenging aspects of new vaccine development for viruses, bacteria and parasites is overcoming problems associated with antigenic variation. In the picornavirus family, antigenic variation is promoted through genetic instability and the evolution of immunodominant, highly variant epitopes within the capsid structure. Immune responses to these epitopes result in isolate-, strain- ...
SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health